Published in J Virol Methods on February 01, 1984
Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J Clin Microbiol (1984) 2.03
Comparison of five different methods of rubella IgM antibody testing. J Clin Pathol (1985) 1.21
The avidity of specific IgM detected in primary rubella and reinfection. Epidemiol Infect (1990) 0.85
Diagnosis of postnatally acquired rubella by use of three enzyme-linked immunosorbent assays for specific immunoglobulins G and M and single radial hemolysis for specific immunoglobulin G. J Clin Microbiol (1984) 0.84
Development and evaluation of a capture enzyme-linked immunosorbent assay for determination of rubella immunoglobulin M using monoclonal antibodies. J Clin Microbiol (1987) 0.82
Fluoroimmunoassay for detection of rubella-specific immunoglobulin M: comparison with indirect enzyme immunoassay and mu-chain capture. J Clin Microbiol (1985) 0.81
Development of a highly specific and sensitive rubella immunoglobulin M antibody capture enzyme immunoassay that uses enzyme-labeled antigen. J Clin Microbiol (1990) 0.78
Detection of immunoglobulins G and M to rubella virus by time-resolved immunofluorometry. J Clin Microbiol (1990) 0.77
Public Health Laboratory Service IgM antibody capture enzyme linked immunosorbent assay for detecting rubella specific IgM. J Clin Pathol (1985) 0.75
HIV seroprevalence among women attending antenatal clinics in London. Lancet (1992) 4.46
Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet (1981) 4.44
Serum IgM and IgG responses in postnatally acquired rubella. Lancet (1969) 4.16
Rubella antibody measured by radial haemolysis. Characteristics and performance of a simple screening method for use in diagnostic laboratories. J Hyg (Lond) (1980) 4.13
A serological method for demonstrating recent infection by rubella virus. Br Med J (1967) 4.07
A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet (1995) 3.93
Monarch Bt-corn paper questioned. Nat Biotechnol (1999) 3.23
Clinical trial with inactivated hepatitis A vaccine and recommendations for its use. BMJ (1992) 2.76
Conventional tissue culture compared with rapid immunofluorescence for identifying Chlamydia trachomatis in specimens from patients attending a genitourinary clinic. Genitourin Med (1985) 2.54
Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ (1989) 2.48
Serological assessment of rubella during pregnancy. Br Med J (1970) 2.37
The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev (1994) 2.32
The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect (2000) 2.25
Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys. Brain (2003) 2.24
Brain asymmetries in autism and developmental language disorder: a nested whole-brain analysis. Brain (2004) 2.23
Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer (2009) 2.18
Effects of a minor isoleucyl tRNA on heterologous protein translation in Escherichia coli. J Bacteriol (1995) 2.14
Chlamydial serology in fertile and infertile women. Lancet (1984) 2.10
A rationalised virological electron microscope specimen testing policy. PHLS North West Viral Gastroenteritis and Electron Microscopy Subcommittee. J Clin Pathol (1999) 2.09
Detection of rubella-specific IgM in subclinical rubella reinfection in pregnancy. Lancet (1985) 2.08
Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus. J Infect Dis (1983) 2.07
DNA chips: an array of possibilities. Nat Biotechnol (1998) 1.95
Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Community Health (1989) 1.92
Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet (1983) 1.91
Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1. Clin Exp Immunol (1996) 1.90
Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia. Ann Intern Med (1983) 1.89
Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect (1995) 1.89
Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet (1981) 1.86
Hepatitis B vaccine boosting among young healthy adults. Lancet (1994) 1.85
Rubella-specific serum and nasopharygeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM. Lancet (1975) 1.78
Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma. Lancet (1972) 1.73
A comparison of three tests for rubella antibody screening. J Clin Pathol (1979) 1.71
Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J (Clin Res Ed) (1982) 1.66
Prevalence of antibodies to Norwalk virus in England: detection by enzyme-linked immunosorbent assay using baculovirus-expressed Norwalk virus capsid antigen. J Clin Microbiol (1993) 1.66
Letter: Rubella-specific IgM and a new inhibitor. Br Med J (1974) 1.66
The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics. Antimicrob Agents Chemother (1997) 1.62
Rubella immunity by four different techniques: results of challenge studies. J Med Virol (1980) 1.58
Studies on rubella virus strain variation by kinetic haemagglutination-inhibition tests. J Gen Virol (1970) 1.56
Ten years of serological surveillance in England and Wales: methods, results, implications and action. Int J Epidemiol (2000) 1.55
Fertility in mice requires X-Y pairing and a Y-chromosomal "spermiogenesis" gene mapping to the long arm. Cell (1992) 1.53
No consistent effect of plant diversity on productivity. Science (2000) 1.52
Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiol Infect (1995) 1.50
PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol (1995) 1.47
The distribution of polycomb-group proteins during cell division and development in Drosophila embryos: impact on models for silencing. J Cell Biol (1998) 1.46
Rubella-specific IgM reactivity in sera from cases of infectious mononucleosis. J Hyg (Lond) (1983) 1.45
Rash in early pregnancy. Br Med J (Clin Res Ed) (1983) 1.43
Rubella-specific IgG subclass avidity ELISA and its role in the differentiation between primary rubella and rubella reinfection. Epidemiol Infect (1988) 1.43
Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period. J Clin Pathol (1982) 1.43
Age-specific antibody prevalence to hepatitis A in England: implications for disease control. Epidemiol Infect (1994) 1.43
The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments. Hum Reprod (2001) 1.42
Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule. Commun Dis Rep CDR Rev (1997) 1.40
Quantitation of HIV: correlation with clinical, virological, and immunological status. J Med Virol (1991) 1.40
Cancer associated human papillomaviruses: perinatal transmission and persistence. Br J Obstet Gynaecol (1994) 1.38
Effect of methylcellulose on rectal and colonic pressures in treatment of diverticular disease. Br Med J (1972) 1.36
Rubella-specific IgM detection using Sephacryl S-300 gel filtration. J Clin Pathol (1980) 1.36
End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation (1989) 1.36
Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect (2006) 1.34
Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods (1992) 1.32
Rubella surveillance to June 1994: third joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev (1994) 1.32
Human papovavirus in Papanicolaou smears of urinary sediment detected by transmission electron microscopy. J Clin Pathol (1977) 1.31
Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic. Lancet (1990) 1.30
Lupus anticoagulant in pregnancy. Br J Obstet Gynaecol (1984) 1.30
Persistence of rubella antibody 8-18 years after vaccination. Br Med J (Clin Res Ed) (1984) 1.30
Rubella-specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine-induced immunity after intranasal challenge. J Infect Dis (1980) 1.30
Splenic atrophy in adult coeliac disease: is it reversible? Gut (1981) 1.28
Maternal rubella at St Thomas' Hospital in 1978 and 1986: support for augmenting the rubella vaccination programme. Lancet (1987) 1.26
Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiol Infect (2004) 1.26
New Japanese rubella vaccine: comparative trials. Br Med J (1974) 1.26
Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection. J Clin Virol (1999) 1.26
Antibody capture radioimmunoassay (MACRIA) for coxsackievirus B4 and B5-specific IgM. J Hyg (Lond) (1983) 1.25
Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance. Vaccine (2002) 1.24
Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. J Infect Dis (1999) 1.23
The role of environmental contamination with small round structured viruses in a hospital outbreak investigated by reverse-transcriptase polymerase chain reaction assay. J Hosp Infect (1998) 1.22
Sodium stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid beta-oxidation in Leishmania mexicana amastigotes. Biochem Pharmacol (1987) 1.20
Specific IgG subclass antibody in rubella virus infections. Epidemiol Infect (1988) 1.20
Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees. J Infect Dis (1985) 1.18
Creation of a functioning chimeric mammalian kidney. Kidney Int (1990) 1.17
An evaluation of nine commercial EIA kits for the detection of measles specific IgG. J Virol Methods (1997) 1.17
The Y* rearrangement in mice: new insights into a perplexing PAR. Cytogenet Cell Genet (1998) 1.16
Children who are seen but not referred: hearing assessment after bacterial meningitis. Br J Audiol (1993) 1.15
The prevalence of hepatitis B infection in adults in England and Wales. Epidemiol Infect (1999) 1.14
RAE28, BMI1, and M33 are members of heterogeneous multimeric mammalian Polycomb group complexes. Biochem Biophys Res Commun (1998) 1.14
A comparison of RK-13, vervet monkey kidney and patas monkey kidney cell cultures for the isolation of rubella virus. J Hyg (Lond) (1967) 1.14
Serological study of the epidemiology of mumps virus infection in north-west England. Epidemiol Infect (1990) 1.13
Viral infections of Toronto children during 1965: II. Measles encephalitis and other complications. Can Med Assoc J (1966) 1.12
Perinatal infection and persistence of human papillomavirus types 16 and 18 in infants. J Med Virol (1995) 1.12
A trial of povidone iodine dry powder spray for the prevention of infusion thrombophlebitis. J Hosp Infect (1980) 1.12
Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopes. J Gen Virol (1989) 1.11
The changing epidemiological pattern of hepatitis A in England and Wales. Epidemiol Infect (2002) 1.11
Sites of cadmium uptake in bacteria used for biosorption. Appl Microbiol Biotechnol (1990) 1.11
The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev (1997) 1.10
Rubella vaccines. Lancet (1979) 1.10
Human parvovirus and rubella-like illness. Lancet (1985) 1.10
An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis. Health Technol Assess (2012) 1.10
Herpes simplex virus detection by ELISA: effect of enzyme amplification, nature of lesion sampled and specimen treatment. J Med Virol (1986) 1.09
Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy. Epidemiol Rev (2002) 1.09